Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment.

[1]  Y. Yamaoka,et al.  Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. , 2006, The Journal of surgical research.

[2]  H. Jaeschke.  Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  G. Gores,et al.  Apoptosis and necrosis in the liver: A tale of two deaths? , 2006, Hepatology.

[4]  C. Page,et al.  Phosphodiesterase inhibitors , 2006, British journal of pharmacology.

[5]  D. Banerjee,et al.  In Vitro Phosphorylation by cAMP-dependent Protein Kinase Up-regulates Recombinant Saccharomyces cerevisiae Mannosylphosphodolichol Synthase* , 2005, Journal of Biological Chemistry.

[6]  C. Webster,et al.  Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[7]  A. Herling,et al.  Characterization of adenosine-A1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies. , 2004, Diabetes.

[8]  H. Ueki,et al.  Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase. , 2004, Biological & pharmaceutical bulletin.

[9]  J. Heemskerk,et al.  Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. , 2004, Biochemical pharmacology.

[10]  Hartmut Jaeschke,et al.  Apoptosis and necrosis in liver disease , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[11]  K. Felekkis,et al.  Blood First Edition Paper, prepublished online November 13, 203; DOI 10.1182/blood-203-06-2154 Among Circulating Hematopoietic Cells, B-CLL Uniquely Expresses Functional EPAC1 But EPAC1-Mediated Rap1 Activation Does Not Account For PDE4 Inhibitor-Induced , 2022 .

[12]  S. Zahler,et al.  Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. , 2003, Cardiovascular research.

[13]  H. Said,et al.  A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKA-mediated pathway. , 2003, American journal of physiology. Cell physiology.

[14]  H. Jaeschke,et al.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. , 2003, Gastroenterology.

[15]  M. Feldmann,et al.  Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: implications for rheumatoid arthritis , 2003, Arthritis research & therapy.

[16]  S. Døskeland,et al.  cAMP effector mechanisms. Novel twists for an ‘old’ signaling system , 2003, FEBS letters.

[17]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[18]  T. Minor,et al.  Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts , 2001, Cellular and Molecular Life Sciences (CMLS).

[19]  J. Lemasters,et al.  Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers , 2000, Hepatology.

[20]  E. Vizi,et al.  Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. , 1997, European journal of pharmacology.

[21]  G. Mellgren,et al.  Novel (Rp)-cAMPS Analogs as Tools for Inhibition of cAMP-kinase in Cell Culture , 1995, The Journal of Biological Chemistry.

[22]  N. Suttorp,et al.  Role of phosphodiesterases in the regulation of endothelial permeability in vitro. , 1993, The Journal of clinical investigation.

[23]  C. Raetz,et al.  Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. , 1992, The Journal of biological chemistry.

[24]  G. Tortora,et al.  Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. , 1992, Cancer research.

[25]  Susan S. Taylor,et al.  Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. , 1990, The Journal of biological chemistry.

[26]  V. Manganiello.  Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. , 1987, Journal of molecular and cellular cardiology.